Nrf2 Transcription Factor Can Directly Regulate mTOR
Open accessAbstract
Nrf2 is a master transcription factor that regulates a wide variety of cellular proteins by recognizing and binding to antioxidant response elements (AREs) in their gene promoter regions. In this study we show that increasing cellular Nrf2 results in transcriptional activation of the gene for mTOR, which is central to the PI3K signaling pathway. This is the case in cells with normal physiological PI3K. However, in cells with abnormally active PI3K increased cellular Nrf2 levels have no effect on mTOR. ChIP assays results show that increased Nrf2 binding is associated with decreased p65 binding and H3-K27me3 signal (marker of gene repression) as well as increased H3-K4me3 signal (marker of gene activation). However, in cells with PI3K activation, no effect of cellular Nrf2 increase on mTOR transcription was observed. In these cells, increasing Nrf2 levels increases Nrf2 promoter binding marginally, whereas p65 binding and H3-K27me3 mark were significantly increased, and H3-K4me3 signal is reduced. Together, these data show for the first time that Nrf2 directly regulates mTOR transcription when the PI3K pathway is intact, whereas this function is lost when PI3K is activated. We have identified a link between the Nrf2 system of sensing environmental stress and mTOR, which is a key cellular protein in metabolism. Studies in cells with activating mutations in the PI3K pathway suggest that Nrf2 transcriptional regulation of mTOR is related to promoter binding of p65 and of methylation of histone residues permissive of transcription.
Integrity signals
Registry
Cites
Statistics
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
Increased levels of Nrf2 can directly activate transcription of the mTOR gene and activate the PI3K signaling pathway, but only in cells with normal physiological PI3K activity.
“However, recently an interesting study has shown that increased levels of Nrf2 can directly activate transcription of the mTOR gene and activate the PI3K signaling pathway. However, this happens only in cells that have a normal physiological PI3K activity (Bendavit et al., 2016).”
From Rapamycin inhibits the secretory phenotype of senescent cells by a Nrf2-independent mechanism (2017) · cites this paper as Bendavit et al., 2016
Cites
Upstream and downstream of mTOR
Hay, N., & Sonenberg, N. (2004) · Genes & Development · doi:10.1101/gad.1212704 · Cited by 4,181 · see citing works
The Rag GTPases Bind Raptor and Mediate Amino Acid Signaling to mTORC1
Sancak, Y., Peterson, T. R., Shaul, Y. D., Lindquist, R. A., Thoreen, C. C., Bar-Peled, L., & Sabatini, D. M. (2008) · Science · doi:10.1126/science.1157535 · Cited by 2,773 · see citing works
Molecular mechanisms of mTOR-mediated translational control
Ma, X. M., & Blenis, J. (2009) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm2672 · Cited by 2,558 · see citing works
Exploiting the PI3K/AKT Pathway for Cancer Drug Discovery
Hennessy, B. T., Smith, D. L., Ram, P. T., Lu, Y., & Mills, G. B. (2005) · Nature Reviews Drug Discovery · doi:10.1038/nrd1902 · Cited by 2,183 · see citing works
Active Genes Are Tri-Methylated at K4 of Histone H3
Santos-Rosa, H., Schneider, R., Bannister, A. J., Sherriff, J., Bernstein, B. E., Emre, N. C. T., Schreiber, S. L., Mellor, J., & Kouzarides, T. (2002) · Nature · doi:10.1038/nature01080 · Cited by 2,138 · see citing works
Growing roles for the mTOR pathway
Sarbassov, D. D., Ali, S. M., & Sabatini, D. M. (2005) · Current Opinion in Cell Biology · doi:10.1016/j.ceb.2005.09.009 · Cited by 1,556 · see citing works
Molecular mechanisms of the Keap1-Nrf2 pathway in stress response and cancer evolution
Taguchi, K., Motohashi, H., & Yamamoto, M. (2011) · Genes to Cells · doi:10.1111/j.1365-2443.2010.01473.x · Cited by 1,478 · see citing works
Genome-wide Map of Nucleosome Acetylation and Methylation in Yeast
Pokholok, D., Harbison, C. T., Levine, S. S., Cole, M. F., Hannett, N. M., Lee, T. I., Bell, G. W., Walker, K., Rolfe, A., Herbolsheimer, E., et al. (2005) · Cell · doi:10.1016/j.cell.2005.06.026 · Cited by 1,433 · see citing works
Polycomb silencing mechanisms and the management of genomic programmes
Schwartz, Y. B., & Pirrotta, V. (2007) · Nature Reviews Genetics · doi:10.1038/nrg1981 · Cited by 868 · see citing works
Malhotra, D., Portales-Casamar, É., Singh, A., Srivastava, S., Arenillas, D. J., Happel, C., Shyr, C., Wakabayashi, N., Kensler, T. W., Wasserman, W. W., et al. (2010) · Nucleic Acids Research · doi:10.1093/nar/gkq212 · Cited by 796 · see citing works
Schübeler, D., MacAlpine, D. M., Scalzo, D., Wirbelauer, C., Kooperberg, C. L., van Leeuwen, F., Gottschling, D. E., O’Neill, L. P., Turner, B. M., Delrow, J. J., et al. (2004) · Genes & Development · doi:10.1101/gad.1198204 · Cited by 795 · see citing works
Histone H3 lysine 4 methylation patterns in higher eukaryotic genes
Schneider, R., Bannister, A. J., Myers, F. A., Thorne, A. W., Crane‐Robinson, C., & Kouzarides, T. (2003) · Nature Cell Biology · doi:10.1038/ncb1076 · Cited by 792 · see citing works
Protocol for the fast chromatin immunoprecipitation (ChIP) method
Nelson, J. D., Denisenko, O. N., & Bomsztyk, K. (2006) · Nature Protocols · doi:10.1038/nprot.2006.27 · Cited by 771 · see citing works
Activation of Nrf2-antioxidant signaling attenuates NFκB-inflammatory response and elicits apoptosis
Li, W., Khor, T. O., Xu, C., Shen, G., Jeong, W.-S., Yu, S., & Kong, A.-N. (2008) · Biochemical Pharmacology · doi:10.1016/j.bcp.2008.07.017 · Cited by 738 · see citing works
Liu, G.-H., Qu, J., & Shen, X. (2008) · Biochimica et Biophysica Acta (BBA) - Molecular Cell Research · doi:10.1016/j.bbamcr.2008.01.002 · Cited by 697 · cited 2× · see citing works
“Interestingly, in cells where p65 and Nrf2 were simultaneously activated, p65 unidirectionally antagonized the transcriptional activity of Nrf2 in a way that was independent of its own transcriptional activity (34).”
BackgroundAkt-dependent regulation of NF-κB is controlled by mTOR and Raptor in association with IKKPreprint
Dan, H. C., Cooper, M. J., Cogswell, P. C., Duncan, J. A., Ting, J. P.-Y., & Baldwin, A. S. (2008) · Genes & Development · doi:10.1101/gad.1662308 · Cited by 638 · see citing works
Madrid, L. V., Wang, C.-Y., D, D. C. G., Schottelius, A. J. G., Baldwin, A. S., & Mayo, M. W. (2000) · Molecular and Cellular Biology · doi:10.1128/mcb.20.5.1626-1638.2000 · Cited by 634 · see citing works
Identification of novel NRF2-regulated genes by ChIP-Seq: influence on retinoid X receptor alpha
Chorley, B. N., Campbell, M. R., Wang, X., Karaca, M., Sambandan, D., Bangura, F., Xue, P., Pi, J., Kleeberger, S. R., & Bell, D. A. (2012) · Nucleic Acids Research · doi:10.1093/nar/gks409 · Cited by 557 · see citing works
Kang, M.-I., Kobayashi, A., Wakabayashi, N., Kim, S.-G., & Yamamoto, M. P. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0308347100 · Cited by 536 · see citing works
Rushmore, T. H., & Pickett, C. B. (1990) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)77351-1 · Cited by 522 · see citing works
Tong, K. I., Padmanabhan, B., Kobayashi, A., Shang, C., Hirotsu, Y., Yokoyama, S., & Yamamoto, M. P. (2007) · Molecular and Cellular Biology · doi:10.1128/mcb.00753-07 · Cited by 447 · see citing works
KEAP1 E3 Ligase-Mediated Downregulation of NF-κB Signaling by Targeting IKKβ
Lee, D.-F., Kuo, H.-P., Liu, M., Chou, C.-K., Xia, W., Du, Y., Shen, J., Chen, C.-T., Huo, L., Hsu, M.-C., et al. (2009) · Molecular Cell · doi:10.1016/j.molcel.2009.07.025 · Cited by 399 · see citing works
Nuclear factor p65 interacts with Keap1 to repress the Nrf2-ARE pathway
Yu, M., Li, H., Liu, Q., Liu, F., Tang, L., Li, C., Yuan, Y., Zhan, Y., Xu, W., Li, W., et al. (2011) · Cellular Signalling · doi:10.1016/j.cellsig.2011.01.014 · Cited by 319 · see citing works
mTOR inhibitors in cancer therapy
Zaytseva, Y. Y., Valentino, J. D., Gulhati, P., & Evers, B. M. (2012) · Cancer Letters · doi:10.1016/j.canlet.2012.01.005 · Cited by 292 · see citing works
Rushworth, S. A., Zaitseva, L., Murray, M. Y., Shah, N. M., Bowles, K. M., & MacEwan, D. J. (2012) · Blood · doi:10.1182/blood-2012-04-422121 · Cited by 290 · see citing works
EZH2 Methyltransferase and H3K27 Methylation in Breast Cancer
Yoo, K. H., & Hennighausen, L. G. (2012) · International Journal of Biological Sciences · doi:10.7150/ijbs.8.59 · Cited by 260 · see citing works
Nrf2 protects against airway disorders
Cho, H., & Kleeberger, S. R. (2009) · Toxicology and Applied Pharmacology · doi:10.1016/j.taap.2009.07.024 · Cited by 237 · see citing works
The rise of antioxidant signaling—The evolution and hormetic actions of Nrf2
Maher, J. M., & Yamamoto, M. P. (2010) · Toxicology and Applied Pharmacology · doi:10.1016/j.taap.2010.01.011 · Cited by 231 · see citing works
mTOR Signaling, Function, Novel Inhibitors, and Therapeutic Targets
Watanabe, R., Liu, W., & Huang, J. (2011) · Journal of Nuclear Medicine · doi:10.2967/jnumed.111.089623 · Cited by 186 · see citing works
Shen, G., & Kong, A. T. (2009) · Biopharmaceutics & Drug Disposition · doi:10.1002/bdd.680 · Cited by 185 · see citing works
Pan, H., Wang, H., Wang, X., Zhu, L., & Mao, L. (2012) · Mediators of Inflammation · doi:10.1155/2012/217580 · Cited by 179 · see citing works
Ha, K.-N., Chen, Y., Cai, J.-Y., & Sternberg, P. (2006) · Investigative Ophthalmology and Visual Science · doi:10.1167/iovs.05-1322 · Cited by 161 · see citing works
Yamadori, T., Ishii, Y., Homma, S., Morishima, Y., Kurishima, K., Itoh, K., Yamamoto, M. P., Minami, Y., Noguchi, M., & Hizawa, N. (2012) · Oncogene · doi:10.1038/onc.2011.628 · Cited by 151 · see citing works
Kloo, B., Nagel, D., Pfeifer, M., Grau, M., Düwel, M., Vincendeau, M., Dörken, B., Lenz, P., Lenz, G., & Krappmann, D. (2010) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1008969108 · Cited by 145 · see citing works
ARE- and TRE-mediated Regulation of Gene Expression
Xie, T., Belinsky, M. G., Xu, Y., & Jaiswal, A. K. (1995) · Journal of Biological Chemistry · doi:10.1074/jbc.270.12.6894 · Cited by 142 · see citing works
Shibata, T., Saito, S., Kokubu, A., Suzuki, T., Yamamoto, M. P., & Hirohashi, S. (2010) · Cancer Research · doi:10.1158/0008-5472.can-10-0384 · Cited by 128 · see citing works
Guichard, S. M., Curwen, J., Bihani, T., D’Cruz, C. M., Yates, J. W. T., Grondine, M. R., Howard, Z., Davies, B. R., Bigley, G., Klinowska, T. C. M., et al. (2015) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-15-0365 · Cited by 126 · see citing works
Loignon, M., Miao, W., Hu, L., Bier, A., Bismar, T. A., Scrivens, P. J., Mann, K. K., Basik, M., Bouchard, A., Fiset, P., et al. (2009) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-08-1186 · Cited by 99 · see citing works
Self-citationJohnston, S. R. D. (2015) · Journal of the National Cancer Institute · doi:10.1093/jnci/djv212 · Cited by 92 · see citing works
Targeting the mTOR Signaling Pathway in Neuroendocrine Tumors
Chan, J. A., & Kulke, M. H. (2014) · Current Treatment Options in Oncology · doi:10.1007/s11864-014-0294-4 · Cited by 91 · see citing works
Jin, R., Song, Z., Yu, S., Piazza, A., Nanda, A., Penninger, J. M., Granger, D. N., & Li, G. (2011) · Stroke · doi:10.1161/strokeaha.110.601369 · Cited by 74 · see citing works
NRF2 Pathway Activation and Adjuvant Chemotherapy Benefit in Lung Squamous Cell Carcinoma
Cescon, D. W., She, D., Sakashita, S., Zhu, C., Pintilie, M., Shepherd, F. A., & Tsao, M. (2015) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-14-2206 · Cited by 61 · see citing works
Clinical development of mTOR inhibitors in breast cancer
Vicier, C., Dieci, M. V., Arnedos, M., Delaloge, S., Viens, P., & André, F. (2014) · Breast Cancer Research · doi:10.1186/bcr3618 · Cited by 61 · see citing works
Nrf2 Negatively Regulates Melanogenesis by Modulating PI3K/Akt Signaling
Shin, J., Kim, M. Y., Sohn, K., Jung, S.-Y., Lee, H.-E., Lim, J. W., Kim, S., Lee, Y., Im, M., Seo, Y., et al. (2014) · PLoS ONE · doi:10.1371/journal.pone.0096035 · Cited by 60 · see citing works
Jin, W., Zhu, L., Guan, Q., Chen, G., Wang, Q. F., Yin, H. X., Hang, C. H., Shi, J. X., & Wang, H. D. (2008) · PubMed · Cited by 56 · see citing works
Verma, A. K., Yadav, A., Dewangan, J., Singh, S. V., Mishra, M., Singh, P. K., & Rath, S. K. (2015) · Redox Biology · doi:10.1016/j.redox.2015.06.020 · Cited by 54 · see citing works
Chuang, J., Huang, J.-Y., Tsai, S., Sun, H. S., Yang, S., Chuang, P., Huang, B., & Ching, C. (2015) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2015.08.011 · Cited by 43 · see citing works
H2S mitigates severe acute pancreatitis through the PI3K/AKT-NF-κB pathwayin vivo
Rao, C.-Y., Lan-ying, F., Hu, C.-L., Chen, D.-X., Gan, T., Wang, Y., & Zhao, X. (2015) · World Journal of Gastroenterology · doi:10.3748/wjg.v21.i15.4555 · Cited by 38 · see citing works
Harada, S., Nakagawa, T., Yokoe, S., Edogawa, S., Takeuchi, T., Inoue, T., Higuchi, K., & Asahi, M. (2015) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.115.226431 · Cited by 33 · see citing works
Page, C. L., Koumakpayi, I. H., Lessard, L., Fred Saad, C., & Mes‐Masson, A. (2005) · The Prostate · doi:10.1002/pros.20291 · Cited by 30 · see citing works
Novel role of NF-κB-p65 in antioxidant homeostasis in human kidney-2 cells
George, L. E., Lokhandwala, M. F., & Asghar, M. (2012) · American Journal of Physiology-Renal Physiology · doi:10.1152/ajprenal.00006.2012 · Cited by 27 · see citing works
RagD gene expression and NRF2 mutations in lung squamous cell carcinomas
Sasaki, H., Shitara, M., Yokota, K., Hikosaka, Y., Moriyama, S., Yano, M., & Fujii, Y. (2012) · Oncology Letters · doi:10.3892/ol.2012.938 · Cited by 21 · see citing works
T cell-to-T cell clustering enhances NF-κB activity by a PI3K signal mediated by Cbl-b and Rho
Herndon, T. M., Pirone, D. M., Tsokos, G. C., & Chen, C. S. (2005) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2005.05.064 · Cited by 9 · see citing works
Flagged first, then by citations
Cited by
Sorted by citations
The Keap1-Nrf2 System: A Mediator between Oxidative Stress and Aging
Yu, C., & Xiao, J.-H. (2021) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2021/6635460 · Cited by 537 · see citing works
Modulating NRF2 in Disease: Timing Is Everything
Dodson, M. B., de la Vega, M. R., Cholanians, A. B., Schmidlin, C. J., Chapman, E., & Zhang, D. D. (2018) · The Annual Review of Pharmacology and Toxicology · doi:10.1146/annurev-pharmtox-010818-021856 · Cited by 540 · see citing works
Nrf2–ARE signaling in cellular protection: Mechanism of action and the regulatory mechanisms
Shaw, P., & Chattopadhyay, A. (2019) · Journal of Cellular Physiology · doi:10.1002/jcp.29219 · Cited by 431 · see citing works
Rapamycin inhibits the secretory phenotype of senescent cells by a Nrf2-independent mechanism
Wang, R., Yu, Z., Sunchu, B., Shoaf, J., Dang, I., Zhao, S., Caples, K., Bradley, L., Beaver, L. M., Ho, E., et al. (2017) · Aging Cell · doi:10.1111/acel.12587 · Cited by 360 · see citing works
Acne vulgaris: The metabolic syndrome of the pilosebaceous follicle
Melnik, B. C. (2017) · Clinics in Dermatology · doi:10.1016/j.clindermatol.2017.09.006 · Cited by 197 · see citing works
The Role of Nrf2 in the Antioxidant Cellular Response to Medical Ozone Exposure
Galiè, M., Covi, V., Tabaracci, G., & Malatesta, M. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20164009 · Cited by 177 · see citing works
Milk’s Role as an Epigenetic Regulator in Health and Disease
Melnik, B. C., & Schmitz, G. (2017) · Diseases · doi:10.3390/diseases5010012 · Cited by 113 · see citing works
The mTORC2 signaling network: targets and cross-talks
Ragupathi, A., Kim, C., & Jacinto, E. (2024) · Biochemical Journal · doi:10.1042/bcj20220325 · Cited by 113 · see citing works
Nrf2-interacting nutrients and COVID-19: time for research to develop adaptation strategies
the ARIA group, Bousquet, J., Cristol, J., Czarlewski, W., Antó, J. M., Martineau, A. R., Haahtela, T., Fonseca, S. C., Iaccarino, G., Blain, H., et al. (2020) · Clinical and Translational Allergy · doi:10.1186/s13601-020-00362-7 · Cited by 80 · see citing works
Regulation of Wound Healing by the NRF2 Transcription Factor—More Than Cytoprotection
Hiebert, P., & Werner, S. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20163856 · Cited by 78 · see citing works
Normal and Pathological NRF2 Signalling in the Central Nervous System
Heurtaux, T., Bouvier, D. S., Bénani, A., Helgueta, S., Frauenknecht, K. B. M., Mittelbronn, M. G. A., & Sinkkonen, L. (2022) · Antioxidants · doi:10.3390/antiox11081426 · Cited by 76 · see citing works
Oxidative Stress-Driven Cellular Senescence: Mechanistic Crosstalk and Therapeutic Horizons
Stojanović, B., Jovanovic, I., Stojanovic, M. D., Stojanović, B., Kovačević, V., Radosavljević, I., Jovanović, D., Kovačević, M. M., Zornić, N., Arsić, A. A., et al. (2025) · Antioxidants · doi:10.3390/antiox14080987 · Cited by 83 · see citing works
Systems-Level Feedbacks of NRF2 Controlling Autophagy upon Oxidative Stress Response
Kapuy, O., Papp, D., Vellai, T., Bánhegyi, G., & Korcsmaros, T. D. (2018) · Antioxidants · doi:10.3390/antiox7030039 · Cited by 74 · see citing works
Gureev, A. P., Popov, V. N., & Starkov, A. A. (2020) · Experimental Neurology · doi:10.1016/j.expneurol.2020.113285 · Cited by 73 · see citing works
NRF2 and Mitochondrial Function in Cancer and Cancer Stem Cells
Panieri, E., Pinho, S., Afonso, G. J. M., Oliveira, P. J., Cunha‐Oliveira, T., & Saso, L. (2022) · Cells · doi:10.3390/cells11152401 · Cited by 68 · see citing works
Ravi, V., Jain, A., Khan, D., Ahamed, F., Mishra, S., Giri, M., Inbaraj, M., Krishna, S., Sarikhani, M., Maity, S., et al. (2019) · Nucleic Acids Research · doi:10.1093/nar/gkz648 · Cited by 67 · see citing works
Neuroprotection during Thrombectomy for Acute Ischemic Stroke: A Review of Future Therapies
Dammavalam, V., Lin, S., Nessa, S., Daksla, N., Stefanowski, K., Costa, A., & Bergese, S. D. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms25020891 · Cited by 55 · see citing works
Ohl, K., Fragoulis, A., Klemm, P., Baumeister, J., Klock, W., Verjans, E., Böll, S., Möllmann, J., Lehrke, M., Costa, I. G., et al. (2018) · Frontiers in Immunology · doi:10.3389/fimmu.2018.01552 · Cited by 55 · see citing works
Martín‐Montañez, E., Valverde, N., de Guevara‐Miranda, D. L., Lara, E., Romero‐Zerbo, S., Millón, C., Boraldi, F., Ávila‐Gámiz, F., Pérez-Cano, A. M., Garrido‐Gil, P., et al. (2021) · Redox Biology · doi:10.1016/j.redox.2021.102095 · Cited by 47 · see citing works
Ji, L., Moghal, N., Zou, X., Fang, Y., Hu, S., Wang, Y., & Tsao, M. (2022) · Cancer Medicine · doi:10.1002/cam4.5311 · Cited by 46 · see citing works
Wang, S., Liu, C., Zhongyi, S., Yan, P., He, L., Huang, K., Li, C., & Tian, J. (2017) · Scientific Reports · doi:10.1038/s41598-017-04384-3 · Cited by 46 · see citing works
Melnik, B. C. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22031059 · Cited by 42 · see citing works
Melnik, B. C. (2021) · Biomolecules · doi:10.3390/biom11030404 · Cited by 42 · see citing works
Adinew, G. M., Messeha, S. S., Taka, E., Badisa, R. B., & Soliman, K. F. A. (2022) · Nutrients · doi:10.3390/nu14224787 · Cited by 41 · see citing works
Prem, P. N., Sivakumar, B., Boovarahan, S. R., & Kurian, G. A. (2022) · Phytomedicine · doi:10.1016/j.phymed.2022.154123 · Cited by 36 · see citing works
Aboulkassim, T., Tian, X., Liu, Q., Qiu, D., Hancock, M. A., Wu, J. H., & Batist, G. (2023) · Cell Reports · doi:10.1016/j.celrep.2023.113104 · Cited by 35 · see citing works
Self-citationAn NRF2 Perspective on Stem Cells and Ageing
Dodson, M. B., Anandhan, A., Zhang, D. D., & Madhavan, L. (2021) · Frontiers in Aging · doi:10.3389/fragi.2021.690686 · Cited by 34 · see citing works
Ding, Z., Da, H., Osama, A., Xi, J., Hou, Y., & Fang, J. (2021) · Food and Chemical Toxicology · doi:10.1016/j.fct.2021.112790 · Cited by 34 · see citing works
Oxidative Stress, Inflammation, and Cellular Senescence in Neuropathic Pain: Mechanistic Crosstalk
Stojanović, B., Bevc, I. M., Stojanovic, M. D., Stojanović, B., Lazarević, T., Spasić, M., Petrovic, M., Stefanovic, I., Marković, M., Nešić, J., et al. (2025) · Antioxidants · doi:10.3390/antiox14101166 · Cited by 33 · see citing works
Lysosomes, Autophagy, and Hormesis in Cell Physiology, Pathology, and Age-Related Disease
Moore, M. N. (2020) · Dose-Response · doi:10.1177/1559325820934227 · Cited by 32 · see citing works
Wei, X., Manandhar, L., Kim, H., Chhetri, A., Hwang, J., Jang, G., Park, C., & Park, R. (2025) · Antioxidants · doi:10.3390/antiox14020126 · Cited by 33 · see citing works
Features of increased malignancy in eosinophilic clear cell renal cell carcinoma
Nilsson, H., Lindgren, D., Axelson, H., Brueffer, C., Saal, L. H., Lundgren, J., & Johansson, M. (2020) · The Journal of Pathology · doi:10.1002/path.5532 · Cited by 32 · see citing works
SOX9 Transcriptionally Regulates mTOR-Induced Proliferation of Basal Cell Carcinomas
Kim, A. L., Back, J. H., Chaudhary, S. C., Zhu, Y., Athar, M., & Bickers, D. R. (2018) · Journal of Investigative Dermatology · doi:10.1016/j.jid.2018.01.040 · Cited by 31 · see citing works
Ding, L., Li, W., Li, N., Liang, L., Zhang, X., Jin, H., Shi, H., Storey, K. B., & Hong, M. (2019) · Comparative Biochemistry and Physiology Part C Toxicology & Pharmacology · doi:10.1016/j.cbpc.2019.02.004 · Cited by 31 · see citing works
Ganoderic acid improves 5-fluorouracil-induced cognitive dysfunction in mice
Abulizi, A., Ran, J., Ye, Y., An, Y., Zhang, Y., Huang, Z., Lin, S., Zhou, H., Lin, D., Wang, L., et al. (2021) · Food & Function · doi:10.1039/d1fo03055h · Cited by 30 · see citing works
Klemm, P., Rajendiran, A., Fragoulis, A., Wruck, C. J., Schippers, A., Wagner, N., Bopp, T., Tenbrock, K., & Ohl, K. (2019) · European Journal of Immunology · doi:10.1002/eji.201948285 · Cited by 28 · see citing works
Wang, S., Li, J., Tian, J., Yu, Z., Gao, K., Shao, J., Li, A., Xing, S., Dong, Y., Li, Z., et al. (2018) · Journal of Cellular Physiology · doi:10.1002/jcp.26551 · Cited by 27 · see citing works
Gureev, A. P., Khorolskaya, V. G., Sadovnikova, I. S., Shaforostova, E. A., Cherednichenko, V. R., Burakova, I. Y., Plotnikov, E. Y., & Popov, V. N. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms232315197 · Cited by 26 · see citing works
Wu, J., Ni, Y., Yang, Q., Mao, J., Zhu, X., Tao, S., Kato, K., Zhang, J., Wang, D., Yamanaka, K., et al. (2020) · The Science of The Total Environment · doi:10.1016/j.scitotenv.2020.139425 · Cited by 26 · see citing works
Gureev, A. P., Sadovnikova, I. S., Chernyshova, E. V., Tsvetkova, A. D., Babenkova, P. I., Nesterova, V. V., Krutskikh, E. P., Volodina, D. E., Samoylova, N. A., Andrianova, N. V., et al. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms25115710 · Cited by 22 · see citing works
Mancini, M. C. S., Morelli, A. P., Severino, M. B., Pavan, I. C. B., Zambalde, É. P., Góis, M. M., da Silva, L. G. S., Ruiz, N. Q., Romeiro, C. F., dos Santos, D. F. G., et al. (2022) · Journal of Cellular Biochemistry · doi:10.1002/jcb.30333 · Cited by 21 · see citing works
The Roles of Oxidative Stress in Regulating Autophagy in Methylmercury-induced Neurotoxicity
Wei, Y., Ni, L., Pan, J., Li, X., Xu, B., Deng, Y. L., Yang, T., & Liu, W. (2021) · Neuroscience · doi:10.1016/j.neuroscience.2021.06.026 · Cited by 20 · see citing works
Glorieux, C., Enriquez-Lara, C., & Calderón, P. B. (2024) · Biochemical Pharmacology · doi:10.1016/j.bcp.2024.116729 · Cited by 18 · see citing works
Wang, X., Jiang, Y., Zhang, Q., Tian, X., Sun, Q., Guo, D., Wang, Q., Chai, X., Lei, P., Li, C., et al. (2020) · Journal of Ethnopharmacology · doi:10.1016/j.jep.2020.113404 · Cited by 18 · see citing works
Wójcik, P., Gęgotek, A., Žarković, N., & Skrzydlewska, E. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22189956 · Cited by 18 · see citing works
Li, M., Huang, W., Zhang, Y., Du, Y., Zhao, S., Wang, L., Sun, Y., Sha, B., Yan, J., Ma, Y., et al. (2024) · Cell Death and Disease · doi:10.1038/s41419-024-06808-1 · Cited by 17 · see citing works
Effects of KEAP1 Silencing on the Regulation of NRF2 Activity in Neuroendocrine Lung Tumors
Sparaneo, A., Fabrizio, F. P., la Torre, A., Graziano, P., Maïo, M. D., Fontana, A., Bisceglia, M., Rossi, A., Pizzolitto, S., Maglio, G. D., et al. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20102531 · Cited by 17 · see citing works
Benites, J. F., Valderrama, J. A., Contreras, Á., Enriquez-Lara, C., Pino‐Rios, R., Yáñez, O., & Calderón, P. B. (2023) · Molecules · doi:10.3390/molecules28114323 · Cited by 15 · see citing works
Development of targeted therapy of NRF2high esophageal squamous cell carcinoma
Paiboonrungruang, C., Simpson, E., Xiong, Z., Huang, C. D., Li, J., Li, Y., & Chen, X. L. (2021) · Cellular Signalling · doi:10.1016/j.cellsig.2021.110105 · Cited by 15 · see citing works
Transcription Factor Nrf2 and Mitochondria – Friends or Foes in the Regulation of Aging Rate
Shilovsky, G. A., & Ashapkin, V. V. (2022) · Biochemistry (Moscow) · doi:10.1134/s0006297922120057 · Cited by 13 · see citing works
Aslam, H., Albaqami, F. F., Rehman, N. U., & Shah, F. A. (2025) · Toxicology and Applied Pharmacology · doi:10.1016/j.taap.2025.117281 · Cited by 14 · see citing works
Joaquim Bellmunt, B., Maroto, P., Bonfill, T., Vazquez, F., Perez‐Gracia, J. L., Juanpere-Rodero, N., Hernández‐Prat, A., Hernández‐Llodrà, S., Rovira, A., Juan, O., et al. (2024) · Clinical Genitourinary Cancer · doi:10.1016/j.clgc.2024.102123 · Cited by 13 · see citing works
Kerforne, T., Giraud, S., Danion, J., Thuillier, R., Couturier, P., Hébrard, W., Mimoz, O., & Hauet, T. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20153671 · Cited by 12 · see citing works
NRF2 and STAT3: friends or foes in carcinogenesis?
Arena, A., Romeo, M. A., Benedetti, R., Montani, M. S. G., Santarelli, R., Gonnella, R., D’Orazi, G., & Cirone, M. (2023) · Discover Oncology · doi:10.1007/s12672-023-00644-z · Cited by 12 · see citing works
TNFα enhances trovafloxacin-induced in vitro hepatotoxicity by inhibiting protective autophagy
Ahn, J., Jegal, H., Choi, M., Kim, S., Park, S., Ahn, J.-H., Han, H., Cho, H., Yoon, S., & Oh, J. (2021) · Toxicology Letters · doi:10.1016/j.toxlet.2021.02.009 · Cited by 10 · see citing works
Cancer Prevention and Therapy by Targeting Oxidative Stress Pathways
Saha, S., Saso, L., & Armağan, G. (2023) · Molecules · doi:10.3390/molecules28114293 · Cited by 10 · see citing works
Regulatory factors of Nrf2 in age-related macular degeneration pathogenesis
Hu, Z.-L., Lin, Z.-Y., Ren, W.-S., Liu, B., Zhao, H., & Qin, Q. (2024) · International Journal of Ophthalmology · doi:10.18240/ijo.2024.07.21 · Cited by 9 · see citing works
NRF2 signaling and amino acid metabolism in cancer
Ham, S., Choi, B.-H., & Kwak, M. (2024) · Free Radical Research · doi:10.1080/10715762.2024.2423690 · Cited by 9 · see citing works
Wei, X., Li, D., Feng, C., Mao, H., Zhu, J., Cui, Y., Yang, J., Gao, H., & Wang, C. (2022) · Journal of Dairy Science · doi:10.3168/jds.2022-21869 · Cited by 9 · see citing works
Zhang, S., Shi, W., Ramsay, E. S., Bliskovsky, V. V., Eiden, A. M., Connors, D. E., Steinsaltz, M., Dubois, W., & Mock, B. A. (2019) · Journal of Biological Chemistry · doi:10.1074/jbc.ra119.009779 · Cited by 9 · see citing works
Liu, Z., Deng, M.-Y., Wu, L., & Zhang, S. (2020) · Molecular Medicine · doi:10.1186/s10020-020-00166-2 · Cited by 9 · see citing works
Zhang, G., Liang, Z., Wang, Y., Zhang, Z., & Hoi, M. P. M. (2024) · Antioxidants · doi:10.3390/antiox13101272 · Cited by 8 · see citing works
Casanova-Maldonado, I., Arancibia, D., Lois, P., Peña‐Villalobos, I., & Palma, V. (2023) · Biological Research · doi:10.1186/s40659-023-00444-3 · Cited by 8 · see citing works
The molecular determinants regulating redox signaling in diabetic endothelial cells
Srivastava, S. P., Kopasz-Gemmen, O., Thurman, A., Rajendran, B. K., Selvam, M., Kumar, S., Srivastava, R., Suresh, M. X., Kumari, R., Goodwin, J. E., et al. (2025) · Frontiers in Pharmacology · doi:10.3389/fphar.2025.1563047 · Cited by 9 · see citing works
Ziech, C. C., Rodrigues, N. R., Macedo, G. E., Gomes, K. K., Martins, I. K., Franco, J. L., & Posser, T. (2022) · Drug and Chemical Toxicology · doi:10.1080/01480545.2022.2069802 · Cited by 7 · see citing works
Milk Exosomes and MicroRNAs: Potential Epigenetic Regulators
Melnik, B. C., & Kakulas, F. (2019) · Springer eBooks · doi:10.1007/978-3-319-55530-0_86 · Cited by 7 · see citing works
Immunoregulation: the interplay between metabolism and redox homeostasis
Perpiñán, E., Fueyo, A. S., & Safinia, N. (2023) · Frontiers in Transplantation · doi:10.3389/frtra.2023.1283275 · Cited by 6 · see citing works
Davoudi, F., & Ramazani, E. (2024) · Physiology and Pharmacology · doi:10.61186/phypha.28.2.99 · Cited by 6 · see citing works
The endocrine and epigenetic impact of persistent cow milk consumption on prostate carcinogenesis
Melnik, B. C., John, S. M., Weiskirchen, R., & Schmitz, G. (2022) · Journal of Translational Genetics and Genomics · doi:10.20517/jtgg.2021.37 · Cited by 6 · see citing works
Shi, L., Wang, Z., Xiao, J., Hu, R., Zou, H., Wang, J., Yue, Z., Peng, Q., Jiang, Y., Xue, B., et al. (2025) · International Journal of Molecular Sciences · doi:10.3390/ijms26062818 · Cited by 6 · see citing works
Shrestha, S., Singhal, S. K., Sens, D. A., Somji, S., Davis, B., Guyer, R., Breen, S., Kalonick, M., & Garrett, S. H. (2021) · PLoS ONE · doi:10.1371/journal.pone.0248241 · Cited by 6 · see citing works
Origins and Timing of Emerging Lesions in Advanced Renal Cell Carcinoma
Wallace, A., Porten, S. P., Lo, A. A., Oreper, D., Lounsbury, N., Havnar, C., Pechuan-Jorge, X., Zill, O. A., & Meng, M. V. (2022) · Molecular Cancer Research · doi:10.1158/1541-7786.mcr-21-0590 · Cited by 5 · see citing works
Pérez‐Cano, L., Boccuto, L., Sirci, F., Hidalgo, J. M., Valentini, S., Bosio, M., D’ardhuy, X. L., Skinner, C. D., Cascio, L., Srikanth, S., et al. (2024) · Biomedicines · doi:10.3390/biomedicines12050991 · Cited by 5 · see citing works
Molecular mechanism on autophagy associated cardiovascular dysfunction in Drosophila melanogaster
Zhang, W., Zhou, R., Lei, X., Wang, M., Duan, Q., Miao, Y., Zhang, T., Li, X., Zutong, Z., Wang, L., et al. (2025) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2025.1512341 · Cited by 5 · see citing works
Milk Exosomes and microRNAs: Potential Epigenetic Regulators
Melnik, B. C., & Kakulas, F. (2017) · Springer eBooks · doi:10.1007/978-3-319-31143-2_86-1 · Cited by 5 · see citing works
Moloudi, K., & Haghdoost, S. (2025) · Antioxidants · doi:10.3390/antiox14080986 · Cited by 4 · see citing works
CHML is an NRF2 target gene that regulates mTOR function
Dodson, M. B., Dai, W., Anandhan, A., Schmidlin, C. J., Liu, P., Wilson, N. C., Wei, Y., Kitamura, N., Galligan, J. J., Ooi, A., et al. (2022) · Molecular Oncology · doi:10.1002/1878-0261.13194 · Cited by 4 · see citing works
Insights into Molecular Mediators of Oxidative Stress and Inflammation in Glioblastoma Multiforme
Anitha, T. S., Kuduvalli, S. S., Biswas, I., Mariappan, V., & Mangaiyarkarasi, N. (2020) · SBV Journal of Basic Clinical and Applied Health Science · doi:10.5005/jp-journals-10082-02274 · Cited by 4 · see citing works
Malarz, K., Zioła, P., Zych, D., Rurka, P., & Mrozek‐Wilczkiewicz, A. (2024) · Scientific Reports · doi:10.1038/s41598-024-77575-4 · Cited by 3 · see citing works
Liang, Q., Xu, S., Fang, Y., Wang, X., Xiao, Y., Wang, Y., Li, S., Guo, Q., Cao, Y., Cao, Y., et al. (2026) · Redox Biology · doi:10.1016/j.redox.2026.104046 · Cited by 2 · see citing works
Qin, D., Hu, Z., Han, S., Luo, Y., Yang, F., Xie, T., & Luo, F. (2024) · Food Science and Human Wellness · doi:10.26599/fshw.2024.9250253 · Cited by 2 · see citing works
Porokhovnik, L. N., & Писарев, В. М. (2017) · Russian Journal of Genetics · doi:10.1134/s1022795417080051 · Cited by 2 · see citing works
Awasthi, A., Nain, V., & Puria, R. (2018) · Interdisciplinary Sciences Computational Life Sciences · doi:10.1007/s12539-018-0284-5 · Cited by 2 · see citing works
The PI3K pathway is a downstream effector of NRF2 activation in the esophagus
Subramaniyan, B., Li, Y., Xiong, Z., Paiboonrungruang, C., Bui-Linh, C., Spitz, F. J., & Chen, X. L. (2025) · Translational Oncology · doi:10.1016/j.tranon.2025.102629 · Cited by 1 · see citing works
Porokhovnik, L. N., & Писарев, В. М. (2017) · Генетика · doi:10.7868/s0016675817080057
The Part Breast Milk Plays in Epigenetic Programming
Şahin, Ö. N. (2023) · Springer eBooks · doi:10.1007/978-3-031-33278-4_12
Canine prostate cancer cell transcriptome reveals important dysregulation in PI3K/AKT/mTOR pathway
Kobayashi, P. E., Lainetti, P. D. F., Leis‐Filho, A. F., Delella, F. K., Vicente, I. S. T., Fonseca‐Alves, C. E., & Amorim, R. L. (2025) · Journal of Comparative Pathology · doi:10.1016/j.jcpa.2025.03.190
Nrf2 modulates macrophage foam cells senescence and autophagy activation
Wai, K. W., Tang, Y.-Q., Foo, J. B., Goh, B. H., & Yap, W. H. (2025) · Toxicology Mechanisms and Methods · doi:10.1080/15376516.2025.2595439
Casanova-Maldonado, I., Arancibia, D., Lois, P., Peña‐Villalobos, I., & Palma, V. (2024) · Figshare · doi:10.6084/m9.figshare.26603869
Casanova-Maldonado, I., Arancibia, D., Lois, P., Peña‐Villalobos, I., & Palma, V. (2024) · Figshare · doi:10.6084/m9.figshare.26603866
Design, Synthesis, and Antitumor Activity of D‐13 Derivatives
Wang, X., Hao, H., Gao, Z., Wang, W., Ma, S., Zhao, Y., & Ji, J. (2026) · ChemistrySelect · doi:10.1002/slct.202506961
- Authors
- Bendavit, G., Aboulkassim, T., Hilmi, K., Shah, S., & Batist, G.
- Affiliations
- Jewish General Hospital (CA)
- Corresponding author
- Batist, Gerald
- Venue
- Journal of Biological Chemistry
- Publisher
- Elsevier BV
- Published
- 2016-12
- Volume
- 291
- Issue
- 49
- Pages
- 25476-25488
- ISSN
- 0021-9258 (ISSN-L)
- PMC
- PMC5207248
- OpenAlex
- W2540781052
- Cited by
- 95
- References
- 53
- Citations by year
- 2026: 2 · 2025: 12 · 2024: 15 · 2023: 7 · 2022: 13 · 2021: 12 · 2020: 10 · 2019: 10 · 2018: 7 · 2017: 7
- FWCI
- 4.16
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Licence
- Locations
- Journal of Biological Chemistry (publishedVersion, cc-by)
- Europe PMC (PubMed Central) (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Funders
- Canadian Institutes of Health Research (MOP-126073)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Genomics, phytochemicals, and oxidative stress
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › PI3K/AKT/mTOR signaling in cancer
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › NF-κB Signaling Pathways
- Keywords
- Nrf2, mTOR, PI3K signaling, transcriptional regulation, NF-κB p65, histone methylation, antioxidant response element, promoter binding, gene repression, cellular metabolism
- MeSH terms
- Gene Expression Regulation, Humans, Mutation, Oxidation-Reduction, Promoter Regions, Genetic, Signal Transduction, Phosphatidylinositol 3-Kinases, NF-E2-Related Factor 2, Transcription Factor RelA, TOR Serine-Threonine Kinases, MCF-7 Cells
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review